Control group:Standard medication

3 trials

Sponsors

Health Committee of Shandong Province, Beijing Tiantan Hospital, Capital Medical University, The First Affiliated Hospital Zhejiang University School of Medicine

Conditions

COVID-19Hypertensionischemic cerebrovascular disease

Early Phase 1

The role and mechanism of external counterpulsation in the prevention of hypertension and cardiovascular and cerebrovascular disease in patients with hypertension

Active, not recruitingChiCTR2000029488

Health Committee of Shandong ProvinceHypertension

Start: 2020-03-01Updated: 2020-02-03

Phase 3

Clinical trial of recombinant human TNK tissue-type plasminogen activator for injection (rhTNK-tPA, Mingfule) in the treatment of acute large artery occlusive stroke over time window (4.5-24h onset)

RecruitingChiCTR2100053567

Beijing Tiantan Hospital, Capital Medical Universityischemic cerebrovascular disease

Start: 2022-03-01Updated: 2022-10-17

Unknown Phase

Effects of Fei Gan Granules Combined with Conventional Western Medicine on Short-term Traditional Chinese Medicine Symptoms in Mild to Moderate COVID-19 Patients: A Prospective Clinical Observational Study

Active, not recruitingITMCTR2025000099

The First Affiliated Hospital Zhejiang University School of MedicineCOVID-19

Start: 2024-02-16Updated: 2025-02-03